Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
2°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by NanoVibronix, Inc.
< Previous
1
2
Next >
NanoVibronix Receives Positive Final Results of Independent Lifecycle Testing of PainShield Prompted by Centers for Medicare and Medicaid Services (CMS)
March 28, 2023
From
NanoVibronix, Inc.
Via
Business Wire
Tickers
NAOV
NanoVibronix Files Provisional U.S. Patent Application for UroShield Ultra
March 21, 2023
From
NanoVibronix, Inc.
Via
Business Wire
Tickers
NAOV
NanoVibronix Announces Positive Results from Independent Product Trial of UroShield for Patients with a Spinal Cord Injury
March 14, 2023
From
NanoVibronix, Inc.
Via
Business Wire
Tickers
NAOV
NanoVibronix Regains Nasdaq Compliance
March 03, 2023
From
NanoVibronix, Inc.
Via
Business Wire
Tickers
NAOV
NanoVibronix to Launch Rental Program for PainShield and UroShield
February 22, 2023
From
NanoVibronix, Inc.
Via
Business Wire
Tickers
NAOV
NanoVibronix Announces Reverse Stock Split
February 08, 2023
From
NanoVibronix, Inc.
Via
Business Wire
Tickers
NAOV
NanoVibronix Provides Update on Expanding Access to PainShield
January 18, 2023
From
NanoVibronix, Inc.
Via
Business Wire
Tickers
NAOV
NanoVibronix Announces Results of Annual Meeting of Stockholders Held Today
December 15, 2022
From
NanoVibronix, Inc.
Via
Business Wire
Tickers
NAOV
NanoVibronix Announces Partnership with Peak Medical, Ltd.
December 13, 2022
From
NanoVibronix, Inc.
Via
Business Wire
Tickers
NAOV
NanoVibronix Announces Closing of $2.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
December 01, 2022
From
NanoVibronix, Inc.
Via
Business Wire
Tickers
NAOV
NanoVibronix Announces $2.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
November 29, 2022
From
NanoVibronix, Inc.
Via
Business Wire
Tickers
NAOV
NanoVibronix Receives FDA 510(k) Premarket Clearance for PainShield Plus
November 28, 2022
From
NanoVibronix, Inc.
Via
Business Wire
Tickers
NAOV
NanoVibronix Announces Interim Results of Clinical Study for UroShield
November 16, 2022
From
NanoVibronix, Inc.
Via
Business Wire
Tickers
NAOV
NanoVibronix Provides Business Update in Letter to Shareholders
November 15, 2022
From
NanoVibronix, Inc.
Via
Business Wire
Tickers
NAOV
NanoVibronix Receives Extension to Satisfy Nasdaq Price Requirement
October 19, 2022
From
NanoVibronix, Inc.
Via
Business Wire
Tickers
NAOV
NanoVibronix UroShield Approved for Sale through NHS Internal Supply Chain Contract
September 23, 2022
From
NanoVibronix, Inc.
Via
Business Wire
Tickers
NAOV
NanoVibronix Sets Date for Annual Shareholder Meeting
September 14, 2022
From
NanoVibronix, Inc.
Via
Business Wire
Tickers
NAOV
NanoVibronix Announces Distribution of Series F Preferred Stock to Holders of its Common Stock
September 14, 2022
From
NanoVibronix, Inc.
Via
Business Wire
Tickers
NAOV
NanoVibronix Announces Receipt of Nasdaq Listing Determination; Company to Request Hearing
September 02, 2022
From
NanoVibronix, Inc.
Via
Business Wire
Tickers
NAOV
NanoVibronix Provides Business Update in Letter to Shareholders
August 18, 2022
From
NanoVibronix, Inc.
Via
Business Wire
Tickers
NAOV
NanoVibronix Announces Webinar Series to Promote UroShield
July 12, 2022
From
NanoVibronix, Inc.
Via
Business Wire
Tickers
NAOV
NanoVibronix Strengthening Supply Chain Increasing Efficiency and Scalability
June 29, 2022
From
NanoVibronix, Inc.
Via
Business Wire
Tickers
NAOV
NanoVibronix Reports First Quarter 2022 Financial Results
May 17, 2022
From
NanoVibronix, Inc.
Via
Business Wire
Tickers
NAOV
NanoVibronix Announces FDA 510(k) Submission for PainShield® MD PLUS
May 04, 2022
From
NanoVibronix, Inc.
Via
Business Wire
Tickers
NAOV
NanoVibronix Adds Additional Product to Federal Supply Schedule
April 25, 2022
From
NanoVibronix, Inc.
Via
Business Wire
Tickers
NAOV
NanoVibronix Advances Efforts to Achieve NHS Approval
April 05, 2022
From
NanoVibronix, Inc.
Via
Business Wire
Tickers
NAOV
NanoVibronix Announces PainGuard and UroGuard Approved by Health Canada as Licensed Medical Devices
March 30, 2022
From
NanoVibronix, Inc.
Via
Business Wire
Tickers
NAOV
NanoVibronix Added an Additional National Payer Network in Workers’ Compensation Market
February 07, 2022
From
NanoVibronix, Inc.
Via
Business Wire
Tickers
NAOV
NanoVibronix Extends Reach of UroShield and PainShield through MTSG’s International Network
January 24, 2022
From
NanoVibronix, Inc.
Via
Business Wire
Tickers
NAOV
NanoVibronix Files Three U.S. Patent Applications Further Leveraging Its Innovative Surface Acoustic Wave Technology
January 19, 2022
From
NanoVibronix, Inc.
Via
Business Wire
Tickers
NAOV
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.